Biological
STR-P004
STR-P004 is a biological therapy with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph early_phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
not_yet_recruiting267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
Exploratory Clinical Study on the Safety of STR-P004
NCT07143617
not_yet_recruitingnot_applicable
To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004
NCT07245251
not_yet_recruitingearly_phase_1
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
NCT07003178
Clinical Trials (3)
Showing 3 of 3 trials
NCT07143617Not Applicable
Exploratory Clinical Study on the Safety of STR-P004
NCT07245251Not Applicable
To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004
NCT07003178Early Phase 1
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3